Ryeqo 40/1/0.5 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: relugolix + estradiol + norethisterone acetate
Brand name
(ARTG)
: RYEQO 40/1/0.5 relugolix 40 mg/estradiol 1 mg/norethisterone acetate 0.5 mg film coated tablet bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Ryeqo is indicated in adult women of reproductive age for:, treatment of moderate to severe symptoms of uterine fibroids,,symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1 PHARMACODYNAMIC PROPERTIES).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Round, light yellow to yellow, film-coated tablet, debossed on one side with "415".
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 28 tablets pack
- 3 x 28 tablets (84 tablets total) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient relugolix + estradiol + norethisterone acetate
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
